RFP‐positive, i.e., p53 shRNA‐expressing, lymphoma cells became significantly enriched under MAF treatment in a dose‐dependent manner, identifying the enhanced cytotoxic response of p53EE lymphoma cells as directly p53EE‐mediated (Fig 7B). The gene discussed is TP53; the disease is lymphoma.